SBIR/STTR Reauthorization Webinar

772148322.png
SBIR/STTR Reauthorization Webinar
September 13, 2022

BIO, CSBA, and AdvaMed hosted a special briefing to discuss the success of SBIR/STTR programs, their economic impact, and the important next steps to Federal reauthorization.

The Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs are highly competitive award-based programs that encourage domestic small businesses to engage in Federal Research/Research and Development with the potential for commercialization.

Federal funding for the SBIR/STTR Program will expire on September 30, 2022, and we need your support to ensure timely reauthorization! Hear from successful SBIR/STTR grantees and technical experts on these vital programs. After this webinar, you will be able to effectively advocate for Federal SBIR/STTR program reauthorization.

Make Your Voice Heard by Congress:
Moderators & Speakers
Placeholder Image
John Conrad, MBA
President & CEO
Illinois Biotechnology Innovation Organization (iBIO)
Placeholder Image
Jere W. Glover
JD
LLM, Attorney, Seidman & Associates PC
Placeholder Image
Erika R. Smith, MBA
CEO
ReNetX Bio
Placeholder Image
Maureen Mulvihill, PhD
CEO
Actuated Medical, Inc.
Placeholder Image
Michael P. Wallner, MBA, MPA, PhD
Department Head
Economic Impacts TechLink-A